1 study found for:    NCT00324987
Show Display Options
Rank Status Study
1 Completed Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Biological: Bevacizumab;   Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study

Indicates status has not been verified in more than two years